Ignite Creation Date:
2024-05-05 @ 9:24 PM
Last Modification Date:
2024-10-26 @ 10:03 AM
Study NCT ID:
NCT00874614
Status:
UNKNOWN
Last Update Posted:
2020-02-20
First Post:
2009-04-01
Brief Title:
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant RelapsedRefractory PheochromocytomaParaganglioma
Sponsor:
Molecular Insight Pharmaceuticals Inc
Organization:
Molecular Insight Pharmaceuticals Inc
Organization Data
Organization:
Molecular Insight Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
MIP-IB12B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Molecular Insight Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None